TiMELiNES
Everything has a timeline
TiMELiNES
2023
FDA approves Vowst
Vowst became the first orally administered FDA-approved fecal microbiota product for recurrent C. difficile prevention.
Context
Appears In
Authority
Sources
Taxonomy
Everything has a timeline
2023
Vowst became the first orally administered FDA-approved fecal microbiota product for recurrent C. difficile prevention.
Context
Authority
Taxonomy